Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method

Fabry disease is a lysosomal storage disease arising from a deficiency of the enzyme α-galactosidase A (GLA). The enzyme deficiency results in an accumulation of glycolipids, which over time, leads to cardiovascular, cerebrovascular, and renal disease, ultimately leading to death in the fourth or fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlo-Mas, Josep, Tomsen-Melero, Judit, Corchero, José-Luis, González-Mira, Elisabet, Font, Albert, Pedersen, Jannik N., García-Aranda, Natalia, Cristóbal-Lecina, Edgar, Alcaina-Hernando, Marta, Mendoza, Rosa, Garcia-Fruitós, Elena, Lizarraga, Teresa, Resch, Susanne, Schimpel, Christa, Falk, Andreas, Pulido, Daniel, Royo, Miriam, Schwartz, Simó, Abasolo, Ibane, Pedersen, Jan Skov, Danino, Dganit, Soldevila, Andreu, Veciana, Jaume, Sala, Santi, Ventosa, Nora, Córdoba, Alba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PRA Press 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085735/
https://www.ncbi.nlm.nih.gov/pubmed/34219919
http://dx.doi.org/10.1016/j.supflu.2021.105204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085735/
https://www.ncbi.nlm.nih.gov/pubmed/34219919
http://dx.doi.org/10.1016/j.supflu.2021.105204

Ejemplares similares